CN101439087B - Chinese medicine granule containing salvia root extract and preparation method thereof - Google Patents
Chinese medicine granule containing salvia root extract and preparation method thereof Download PDFInfo
- Publication number
- CN101439087B CN101439087B CN2007101503224A CN200710150322A CN101439087B CN 101439087 B CN101439087 B CN 101439087B CN 2007101503224 A CN2007101503224 A CN 2007101503224A CN 200710150322 A CN200710150322 A CN 200710150322A CN 101439087 B CN101439087 B CN 101439087B
- Authority
- CN
- China
- Prior art keywords
- salviae miltiorrhizae
- master batch
- extractum
- slurry
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 73
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 239000008187 granular material Substances 0.000 title claims description 73
- 238000000605 extraction Methods 0.000 title description 16
- 235000017276 Salvia Nutrition 0.000 title 1
- 240000007164 Salvia officinalis Species 0.000 title 1
- 239000002245 particle Substances 0.000 claims abstract description 98
- 239000002775 capsule Substances 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 122
- 239000007921 spray Substances 0.000 claims description 86
- 239000002002 slurry Substances 0.000 claims description 75
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 63
- 229960004756 ethanol Drugs 0.000 claims description 57
- 239000000203 mixture Substances 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 238000000576 coating method Methods 0.000 claims description 45
- 239000011248 coating agent Substances 0.000 claims description 44
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 35
- 229920002472 Starch Polymers 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 34
- 239000008107 starch Substances 0.000 claims description 34
- 235000019698 starch Nutrition 0.000 claims description 34
- 239000012530 fluid Substances 0.000 claims description 33
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 32
- 241000180649 Panax notoginseng Species 0.000 claims description 32
- 229920001353 Dextrin Polymers 0.000 claims description 27
- 239000004375 Dextrin Substances 0.000 claims description 27
- 235000019425 dextrin Nutrition 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 25
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 24
- 229920003081 Povidone K 30 Polymers 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 239000012141 concentrate Substances 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 238000010410 dusting Methods 0.000 claims description 15
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 15
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 15
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 abstract description 10
- 239000003405 delayed action preparation Substances 0.000 abstract description 5
- 239000011265 semifinished product Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 22
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 22
- 239000008108 microcrystalline cellulose Substances 0.000 description 22
- 229940016286 microcrystalline cellulose Drugs 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 10
- 229920001661 Chitosan Polymers 0.000 description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 8
- 229930195725 Mannitol Natural products 0.000 description 8
- 239000000594 mannitol Substances 0.000 description 8
- 235000010355 mannitol Nutrition 0.000 description 8
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 239000001341 hydroxy propyl starch Substances 0.000 description 5
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 239000007767 bonding agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008899 fufang danshen Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a traditional Chinese medicine granular preparation with radix salviae miltiorrhizae extract and a preparation method thereof. Traditional Chinese medicine spheroidized particles are prepared by using a traditional Chinese medicine extract and a pharmaceutically acceptable carrier. The shapes of the traditional Chinese medicine spheroidized particles are spherical or similar to spheres, and the density of the traditional Chinese medicine spheroidized particles ranges from 0.6 g/ml to 1.3 g/ml. A single dose of the spheroidized particles is small, the medicine taking is convenient, and the granular preparation can be used as a semifinished product of capsules and can also be used for developing sustained and controlled release preparations of traditional Chinese medicine.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation and preparation method thereof, be specifically related to a kind of Chinese medicinal granule that contains Radix Salviae Miltiorrhizae extract and preparation method thereof.
Background technology
Cardiovascular and cerebrovascular disease is to cause human first dead sick the kind, and along with the raising of social life level and the aging of population, the research of cardiovascular and cerebrovascular diseases medicament becomes the focus of drug development.Coronary heart disease is the abbreviation of coronary heart disease, is that a kind of sickness rate is high, and mortality rate is high, and human healthy disease in serious harm, thereby b referred to as " the first human killer ".Angina pectoris is a coronary insufficiency; Cardiac muscle is rapid, of short duration ischemia and the caused clinical syndrome of anoxia; Usually occur in fatigue, heavy meal, catch cold and when excited; Vexed pain, squeezing pain or constriction that the right occurrence scope of metosteon is not clear, patient is conscious to have palpitation, suffocates, sometimes with dying sensation.Ischemia apoplexy (cerebral infarction) all is important opportunitys of its prevention and treatment at acute attack stage and in apoplexy early stage and convalescent period.Hypertension is the modal cardiovascular disease in the world, also is one of maximum epidemic diseases, often causes the complication of internal organs such as the heart, brain, kidney, and human beings'health in serious harm.Show that according to national statistics the existing hyperpietic of China has reached 100,000,000, annual newly-increased more than 3,000,000.Therefore treat and prevent above-mentioned disease to have important effect; These diseases of treatment by Chinese herbs have long history; Especially the folk prescription or the compound preparation that with the Radix Salviae Miltiorrhizae are primary raw material all have definite curative effect; Bringing into play main effect especially like FUFANG DANSHEN PIAN, FUFANG DANSHEN ZHUSHEYE, treating coronary heart disease granule, happy amylan capsule etc., compound red sage root preparation is the focus of recent researches.
The traditional preparation process method of Chinese medicinal granule is to adopt dry method or wet method to process the particulate material of certain particle size Chinese medicine or its extract, when supplying the patient to use with mixing in water for oral taking or swallow.The defective of at present common several kinds of granule preparation technologies and existence thereof: 1. conventional particles preparation technology; Because Chinese medical concrete viscosity is higher, there are problems such as particulate drug loading is low, outward appearance is not attractive in appearance, mouthfeel is poor, the easy moisture absorption mostly in the method for preparing of conventional particles.2. comparatively popular at present fluidized bed granulation technology is that drug powder and various adjuvant are packed in the container, is blown into the air-flow of preference temperature through sieve plate from the bed bottom; Make material mix homogeneously under fluidized state; Begin evenly to spray into binder liq then, powder begins the coalescence granulating, through spraying and drying repeatedly; When granular size meets the requirements, stop spraying, continue dry.This technology can be reduced to the adjuvant amount more than 50% by traditional 80%; The single dose of the grain products of preparation generally can be reduced to 3g to 5g by traditional 10g; But this technology can not thoroughly solve the problem of viscosity of Chinese medicine extract; Used adjuvant can not further reduce, and single agent dose is bigger, and patient's compliance is relatively poor; And use this kind method to be not suitable for processing solid preparations such as capsule; Adopting the granule of fluidized bed granulation technology at present commonly used preparation in addition is cellular, irregular shape; Moisture absorption is more common, and inconvenience is preserved; Particulate specific surface area is bigger, is not suitable for coating.3. also having Chinese medicine or plant amedica extract use fluidized-bed process manufacturing particle diameter is the research of the micropill technology of 700～1500 μ m; But this technology all is that medicine is processed dry powder; Water or other mixing material are as binding agent; Add medicine dry powder while spraying into liquid adhesive, process micropill.The micropill dissolve scattered time limit that at present adopts this explained hereafter is generally all at 40 minutes, and defective such as production process is comparatively complicated, cost is high, the influence factor is more (for example when air humidity is big, can not make), loss is bigger.4. also have to adopt in formulation art and extrude round or extrude the technology that spheronization is made micropill or spheroidal particle, this technology makes the goods support large usage quantity, and drug loading is general below 25%, and dissolve scattered time limit is more than 30 minutes.5. in formulation art, spray or side pressure spray process at the bottom of the fluid bed of employing are also arranged, make Western medicine micropill or spheroidal particle, be used for the exploitation of slow releasing preparation more, so development product generally has slow controlled release characteristics, do not possess the rapid release characteristic.
The rapid release of Chinese medicine and quick acting are importances of the modernization of Chinese medicine, adopt the Chinese medicine of manufacturing of the present invention or plant amedica granule to have fast instant diffusing characteristic.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal granule that contains Radix Salviae Miltiorrhizae extract.
Another object of the present invention is to provide a kind of method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract and realizes through following technical scheme:
Processed by Chinese medicine extract and pharmaceutically acceptable carrier, wherein Chinese medicine extract accounts for 40～90% of percentage by weight, and pharmaceutically acceptable vehicle weight percentage composition is 10～60%; Described Chinese medicine extract is obtained according to following method by following materials of weight proportions: 30～180 parts of Radix Salviae Miltiorrhizaes, 5～40 parts of Radix Notoginseng and 0.3～2.5 part of Borneolum Syntheticum are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 1～5 time, collecting decoction filters; Filtrating concentrates, and adds 0.5～5 times of amount 80～99% ethanol, leaves standstill 12～36 hours; Filter, reclaim ethanol, filtrating is concentrated under 30～80 ℃ of conditions, relative density is 1.05～1.45 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, preferably realizes through following technical scheme:
Weight percentage by Chinese medicine extract is 70～80%, and pharmaceutically acceptable vehicle weight percentage composition is 20～30%; Wherein said Chinese medicine extract is obtained according to following method by following materials of weight proportions: 75～115 parts of Radix Salviae Miltiorrhizaes, 14～20 parts of Radix Notoginseng and 0.8～1.2 part of Borneolum Syntheticum are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 2～4 times, collecting decoction filters, filtrating concentrates, and adds 1～3 times of amount 90～97% ethanol, leaves standstill 18～30 hours, filters, and reclaims ethanol, filtrate be concentrated under 50～75 ℃ of conditions, relative density is 1.20～1.40 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and the best realizes through following technical scheme:
Weight percentage by Chinese medicine extract is 70～80%, and pharmaceutically acceptable vehicle weight percentage composition is 20～30%; Wherein Chinese medicine extract is obtained according to following method by following materials of weight proportions: 90 parts of Radix Salviae Miltiorrhizaes, 17.6 parts of Radix Notoginseng and 1 part of Borneolum Syntheticum are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water three times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 95% ethanol, leaves standstill 24 hours, filters, and reclaims ethanol, filtrate be concentrated under 55～60 ℃ of conditions, relative density is 1.33～1.35 thick paste 1; The Borneolum Syntheticum that will be dissolved in the adequate amount of ethanol joins in the thick paste 1, preparation cost invention Chinese medicine extract.
Chinese medicine extract described in the present invention; Can obtain according to method provided by the invention; Also can get like the preparation of methods such as decocting method, infusion process, percolation, circumfluence method, water extract-alcohol precipitation, alcohol extracting-water precipitating according to the conventional or commonly used method in present technique field; Can be extractum, also can be the effective site of further extraction separation acquisition or the compositions of effective site.
Pharmaceutically acceptable carrier of the present invention can be any preparation Chinese medicinal granule pharmaceutically acceptable carrier commonly used or conventional, and for example: diluent (filler) includes but not limited to sucrose, dextrin, starch, lactose, mannitol, xylitol, chitosan, SHUANGQITANG, soluble starch, Pulvis Talci or water solublity dextrin etc.; Disintegrating agent includes but not limited to starch, sodium carboxymethyl cellulose (CMS-Na), microcrystalline Cellulose (MCC), micropowder silica gel, hydroxypropyl starch, soluble starch, water solublity dextrin; Inclusion agents includes but not limited to alpha-cyclodextrin (α-CD), beta-schardinger dextrin-(β-CD) and N-LOK modified starch etc.; Wetting agent (binding agent) includes but not limited to water, ethanol, polyvinylpyrrolidone (polyvidone), hydroxypropyl cellulose, Polyethylene Glycol above-mentioned adjuvant function such as diluent such as (PEG); Disintegrating agent, wetting agent by the function address, are viscosity modifier in this patent; Preferably microcrystalline cellulose (MCC), micropowder silica gel, Polyethylene Glycol, Pulvis Talci, chitosan; Pulvis Talci, the above-mentioned pharmaceutically acceptable carrier of polyvidone can use separately, also can unite use.Persons of ordinary skill in the art may appreciate that the following emerging pharmaceutically acceptable carrier that can be used for preparing Chinese medicinal granule,, also should be included in protection scope of the present invention if can realize the object of the invention.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and described pharmaceutically acceptable carrier preferably one or more in sucrose, dextrin, starch, lactose, mannitol, xylitol, chitosan, SHUANGQITANG, soluble starch, Pulvis Talci, water solublity dextrin sodium carboxymethyl cellulose (CMS-Na), microcrystalline Cellulose (MCC), micropowder silica gel, hydroxypropyl starch, ethanol, hydroxypropyl cellulose, Polyethylene Glycol, chitosan, polyvidone is united use.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and described pharmaceutically acceptable carrier is preferably: crystalline cellulose element, micropowder silica gel, Polyethylene Glycol, Pulvis Talci, chitosan, Pulvis Talci, polyvidone.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract; Described granule comprises master batch and is positioned at the shell on the master batch, and profile be spherical or type sphere, and bulk density is 0.6～1.3g/m; Dissolve scattered time limit is 0.4～5 minute, and active constituents of medicine is included among master batch and/or the shell.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and its particle diameter is 700～1500 μ m.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and said granule also contains coating, and the weight of coating materials accounts for 2～5wt% of granule gross weight.
The Chinese medicinal granule that the present invention contains Radix Salviae Miltiorrhizae extract adopts the fluidized bed granulation technology to granulate; Common fluidized bed granulation technology is directly packed into powdered substance and is granulated as bed material in the container of fluid bed; And the present invention forms with pharmaceutically acceptable preparing carriers, perhaps is prepared from pharmaceutically acceptable carrier and corresponding Chinese medicine extract dry powder.
The present invention contains the method for preparing of the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and step is following:
(1) preparation of extract: Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 1～5 time, collecting decoction filters; Filtrating concentrates, and adds 0.5～5 times of amount 80～99% ethanol, leaves standstill 12～36 hours; Filter, reclaim ethanol, filtrating is concentrated under 30～80 ℃ of conditions, relative density is 1.05～1.45 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract;
(2) preparation of master batch: i. gets an amount of pharmaceutically acceptable carrier, the perhaps mixture of itself and Chinese medicine extract dry powder, and crushing screening obtains the satisfactory material of granularity; Ii. get the material of a part of step I, drop in spray of fluid bed side or the end spray pot, other gets it filled and learns acceptable carrier and/or Chinese medicine extract and add water and be mixed with slurry; Adopt spray of fluid bed side or end pressure spray process to spray into, and sift out granule, again parent nucleus is dropped in the pot as parent nucleus; Continue to spray and state slurry; The material of remaining step I is sprinkled into fine powder in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, filter out the satisfactory master batch of particle diameter;
(3) preparation of product: it is an amount of to get master batch, and acceptable carrier is an amount of, and extract extractum of the present invention is an amount of; Above-mentioned acceptable carrier is added in the invention described above extract extractum, and it is subsequent use as slurry to mix into suspension; Above-mentioned master batch is dropped in the fluid bed side spray pot, and above-mentioned slurry slowly sprays into, and all sprays into to slurry, processes spheroidal particle.
The present invention contains the method for preparing of the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and preferred steps is following:
(1) preparation of extract: get Radix Salviae Miltiorrhizae 9kg, Radix Notoginseng 1.76kg decocte with water 3 times, decoction liquor is filtered, filtrating concentrates, and precipitate with ethanol left standstill 24 hours, filters, reclaims ethanol, and relative density is 1.33～1.35 when being condensed into thick paste shape to 50～60 ℃, obtains extractum; After getting Borneolum Syntheticum and cyclodextrin or PVP enclose,, obtain compound Salviae Miltiorrhizae extractum with enclose liquid and above-mentioned extractum mix homogeneously, subsequent use;
(2) preparation of master batch: the mixture of getting dextrin and starch weight ratio and being 1: 1 is crossed 200 mesh sieves, and wherein 60-65wt% drops in the fluid bed side spray pot as bed material; 10-15wt% dextrin and starch mixture, amount to the extract extractum of the present invention that accounts for the 15wt% of master batch weight after the dry weight; Add water and be mixed with slurry and spray into, and sift out particle diameter be 180～250 μ m granules as parent nucleus, again parent nucleus is dropped in the pot; Continue to spray and state slurry; In the dusting rifle, the dextrin of surplus and the fine powder of starch mixture are sprinkled into simultaneously, the particle diameter of parent nucleus is grown up, the master batch that filters out particle diameter and be 450～600 μ m is subsequent use;
(3) preparation of product: get the about 450g of master batch; 100～1000g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum; With compound Salviae Miltiorrhizae extractum weight ratio be 18: 25 polyethylene glycol 6000; Perhaps be 7: 25 HPMC and PVP-K30 mixture, wherein HPMC with compound Salviae Miltiorrhizae extractum weight ratio: the PVP-K30 weight ratio is 2: 5; Use dehydrated alcohol with a kind of solution that is formulated as concentration as 15wt% in above-mentioned viscosity adjustment agent polyethylene glycol 6000 or HPMC and the PVP-K30 mixture; Add in the compound Salviae Miltiorrhizae extractum; After the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 19wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
The present invention contains in the method for preparing of Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and the temperature of charge of the spheroidal particle that can said method be obtained is controlled at 37～45 ℃; Transparent coating material water is made into the coating solution of 7.5% (g/ml) again, according to the amount of theory weightening finish 3wt% coating solution is sprayed into coating, process spheroidal particle, its bulk density is 0.76g/ml, and dissolve scattered time limit is 25 seconds.
The present invention contains in the method for preparing of Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, No. 2 capsules of spheroidal particle fill that can said method be obtained, and the 250mg/ grain is processed 10000 of capsules.
" setting of dosage form in the Chinese pharmacopoeia, and in order to distinguish different with technology such as micropill, microcapsules in conjunction with the characteristic of present technique preparing product, was named above-mentioned granule and is spheroidized particle according to version in 2005.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, outside it coating can also be arranged, and the weight of coating materials accounts for the 2-5% of granule gross weight.During the spheroidized particle coating, obviously low (plain particles coating, coating materials consumption are 20-30% to the more common granule coating of the consumption of coating materials, and spheroidized particle coating materials consumption then can be reduced to 2-5% with the adjuvant amount.As required; Coating can be common film coating, also can be enteric film coating, slow controlled release coat etc., and coating materials can be the commonly used or conventional coating materials in any this area; Select according to different needs, the coating process can be carried out according to the conventional method in this area.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, directly uses except can be used as common granule, can also be as intermediate; Be prepared into dosage forms such as capsule; As granule use etc., can be prepared into sustained-release preparation in addition, positioning release medicine preparation etc.
The present invention contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract, and preferred said granule is processed conventional capsule agent or sustained-release preparation.
Spheroidized particle of the present invention has the following advantages:
1. the consumption of adjuvant is few, therefore causes single dose little, and the general each dose of patient is that 0.1～4g gets final product, and can reduce the fear that the patient takes medicine and produced heavy dose.
2. outward appearance is good, granule of the present invention spherical in shape or type spherical, smooth surface rounding, the control of suitable product design quality.
3. physical characteristic is good, prepares in the process at spheroidal particle, and mobility of particle is good, causes that particle size distribution is regular, the fine and close anti-extruding of quality, and wear-resistant, density is big, and (bulk density is 0.6～1.3g/ml), specific surface area is little (has only 0.01～0.03m
2/ g).
4. dissolve scattered time limit is short, and the spheroidal particle dissolve scattered time limit of the present invention that adopts this type of prescription to make is short, is generally 0.4～5 minute.
5. granularity test: according to 2000 editions pharmacopeia regulations, get granule 5 bags of (bottle) or multiple dose packing granule 1 bags (bottle) of single dose packing, claim to decide weight, put in the medicine sieve and sieve.When sieving, will sieve and keep level, about come and go and sieved gently 3 minutes.Can not and can must not cross 8.0% through a sieve through the granule and the powder summation of No. four sieves.Granule of the present invention can not and can meet the pharmacopeia regulation through the granule and the powder summation of No. four sieves through a sieve, and its numerical value is no more than 5.5%.
6. melting test: according to 2000 editions pharmacopeia regulations, get medicinal granule test sample 10g of the present invention, add 20 times of hot water, stirred 5 minutes, observe immediately.Soluble granule is answered off-bottom.
These characteristics can improve patient's the row of complying with, and makes the application of packaging technique become possibility, thereby has solved the moisture absorption (critical wettability is promoted to 85% by 60% of plain particles) of Chinese medicine, problem such as stable; In addition, spheroidized particle of the present invention uses except can be used as common granule, can also be as intermediate or granule, and fill becomes dosage forms such as capsule, can be prepared into sustained-release preparation in addition, positioning release medicine preparation etc.
The specific embodiment
Below in conjunction with specific embodiment the present invention is further described, following this embodiment only is used to the present invention is described and the present invention is not limited.
Embodiment 1
The extraction of extractum: get Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 3 times, decoction liquor filters, and filtrating concentrates, and precipitate with ethanol left standstill 24 hours, filters, reclaims ethanol, and it is subsequent use to relative density 1.33-1.35 (50-60 ℃) to be condensed into the thick paste shape.After getting Borneolum Syntheticum and cyclodextrin or PVP enclose, enclose liquid and extractum mix homogeneously, subsequent use;
The preparation of master batch: the weight ratio of getting dextrin and starch is that 1: 1 mixture is crossed 200 mesh sieves; Wherein 65% as in the bed material input fluid bed side spray pot; Other gets starch and adds water and be mixed with starch slurry (15%) and spray into as slurry, and sifts out granule (particle diameter is 180-250 μ) as parent nucleus, parent nucleus is dropped in the pot again; Continue the spray starch slurry; 35% the dextrin of remainder and the fine powder of starch are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 450 μ-600 μ to filter out particle diameter.
The preparation of product: get the about 450g of master batch, the about 50g of microcrystalline Cellulose (200 order), polyethylene glycol 6000 (heating and melting) are approximately
500G, the extractum of 10000 dosage of extractum; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and adding water, to mix into solid content be 30% binding agent; Master batch is dropped in the fluid bed side spray pot; Slurry is slowly sprayed into; Constantly be dried to simultaneously slurry and all spray into and process spheroidal particle, temperature of charge is controlled at 55 degrees centigrade, and coating material OPAGLOS 2 waters that reuse is transparent are made into 7.5% coating solution; Amount according to theory weightening finish 3% sprays into coating with coating solution, processes spheroidal particle.Bulk density is 0.76g/ml.With No. 2 capsules of the spheroidal particle fill that obtains, every dress 0.125g processes 10000 of capsules.
Embodiment 2
The extraction of extractum: Radix Salviae Miltiorrhizae 1800g, Radix Notoginseng 400g and Borneolum Syntheticum 3g are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 5 times, collecting decoction filters, filtrating concentrates, and adds 5 times of amount 80% ethanol, leaves standstill 12 hours, filters, and reclaims ethanol, filtrate be concentrated under 80 ℃ of conditions, relative density is 1.05～1.15 thick paste 1; Join in the thick paste 1 preparation cost invention Chinese medicine extract with finely divided ice.
The preparation of master batch: the mixture of getting micropowder silica gel and chitosan weight ratio and being 1: 1 is crossed 200 mesh sieves; Wherein 65% as in the bed material input fluid bed side spray pot; Other gets PVP K30 and adds water, extract, is mixed with bonding agent-spray into as slurry, and sift out particle diameter be 120-180 μ granule as parent nucleus, again parent nucleus is dropped in the pot; Continue the spray starch slurry; 35% the micropowder silica gel of remainder and the fine powder of chitosan are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 200 μ-300 μ to filter out particle diameter.
The preparation of product: get the about 300g of master batch, the about 250g of microcrystalline Cellulose (200 order), the about 14g of micropowder silica gel, extractum 200g; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and it is subsequent use as slurry to mix into uniform suspension; Master batch is dropped in the fluid bed side spray pot; Slurry is slowly sprayed into, constantly be dried to simultaneously slurry and all spray into and process spheroidal particle, coating material OPAGLOS 2 waters that reuse is transparent are made into 7.5% coating solution; Amount according to theory weightening finish 3% sprays into coating with coating solution, processes spheroidal particle.Particulate bulk density 0.93g/ml, with No. 00 capsule of the spheroidal particle fill that obtains, every dress 0.70g processes capsule.
Embodiment 3
The extraction of extractum: Radix Salviae Miltiorrhizae 1500g, Radix Notoginseng 70g and Borneolum Syntheticum 25g are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 2 times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 90% ethanol, leaves standstill 36 hours, filters, and reclaims ethanol, filtrate be concentrated under 30 ℃ of conditions, relative density is 1.05～1.35 thick paste 1; The Borneolum Syntheticum that will be dissolved in the adequate amount of ethanol joins in the thick paste 1, preparation cost invention Chinese medicine extract.
The preparation of master batch: the mixture of getting dextrin and starch weight ratio and being 1: 1 is crossed 200 mesh sieves; Wherein 65% as in the bed material input fluid bed side spray pot; Other gets starch, extract (account for after giving money as a gift master batch weight 15%) and adds water and be mixed with slurry and spray into, and sifts out granule (particle diameter is 180～250 μ) as parent nucleus, parent nucleus is dropped in the pot again; Continue the spray starch slurry; 35% the dextrin of remainder and the fine powder of starch are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 300 μ～400 μ to filter out particle diameter.
The preparation of product: get the about 450g of master batch, the about 50g of microcrystalline Cellulose (200 order), polyethylene glycol 6000 (heating and melting) are approximately
500G, extractum 1000g; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and adding water, to mix into solid content be 30% binding agent; Master batch is dropped in the fluid bed side spray pot; Slurry is slowly sprayed into, constantly be dried to simultaneously slurry and all spray into and process spheroidal particle, temperature of charge is controlled at 55 degrees centigrade; Coating material OPAGLOS 2 waters that reuse is transparent are made into 7.5% coating solution; Amount according to theory weightening finish 3% sprays into coating with coating solution, processes spheroidal particle, and bulk density is 0.76g/ml; With No. 2 capsules of the spheroidal particle fill that obtains, every dress 0.125g processes capsule.
Embodiment 4
The extraction of extractum: it is subsequent use to get Radix Salviae Miltiorrhizae 1150g, Radix Notoginseng 200g and Borneolum Syntheticum 12g; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 4 times, collecting decoction filters, filtrating concentrates, and adds 3 times of amount 90% ethanol, leaves standstill 30 hours, filters, and reclaims ethanol, filtrate be concentrated under 75 ℃ of conditions, relative density is 1.20～1.40 thick paste 1; The Borneolum Syntheticum that will be dissolved in the adequate amount of ethanol joins in the thick paste 1, preparation cost invention Chinese medicine extract.
The preparation of master batch: the mixture of getting dextrin and microcrystalline Cellulose weight ratio and being 1: 1 is crossed 200 mesh sieves; Wherein 65% as in the bed material input fluid bed side spray pot; Other gets PVP K30 and adds water and be mixed with bonding agent (5%) and spray into as slurry, and sift out particle diameter be 180～250 μ granules as parent nucleus, again parent nucleus is dropped in the pot; Continue the spray starch slurry; 35% the dextrin of remainder and the fine powder of microcrystalline Cellulose are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 300 μ～400 μ to filter out particle diameter.
The preparation of product: get the about 1000g of master batch, in 5% the polyvidone solution, add extractum an amount of (being equivalent to 50 kilograms of medical materials); In 5% the polyvidone solution, add that extractum is an amount of, adding water, to mix into solid content be that 30% suspension is subsequent use as slurry; Master batch is dropped in the fluid bed side spray pot; Slurry is slowly sprayed into, constantly be dried to simultaneously slurry and all spray into and process spheroidal particle, coating material OPAGLOS 2 waters that reuse is transparent are made into 7.5% coating solution; Amount according to theory weightening finish 3% sprays into coating with coating solution, processes spheroidal particle.
Embodiment 5
The extraction of extractum: it is subsequent use to get Radix Salviae Miltiorrhizae 750g, Radix Notoginseng 140g and Borneolum Syntheticum 8g; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 2 times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 97% ethanol, leaves standstill 18 hours, filters, and reclaims ethanol, filtrate be concentrated under 50 ℃ of conditions, relative density is 1.20～1.30 thick paste 1; Join in the thick paste 1 preparation cost invention Chinese medicine extract with finely divided ice.
The preparation of master batch: the mixture of getting dextrin and microcrystalline Cellulose weight ratio and being 2: 1 is crossed 100 mesh sieves; Wherein 75% as in the bed material input fluid bed side spray pot; Other gets PVP K30 and adds water, extract, is mixed with bonding agent-spray into as slurry, and sift out particle diameter be 100-200 μ granule as parent nucleus, again parent nucleus is dropped in the pot; Continue the spray starch slurry; 35% the dextrin of remainder and the fine powder of microcrystalline Cellulose are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 200 μ-300 μ to filter out particle diameter.
The preparation of product: get the about 800g of master batch, the about 190g of microcrystalline Cellulose, the about 35g of micropowder silica gel, extractum 250g; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and it is subsequent use as slurry to mix into uniform suspension; Master batch is dropped in the fluid bed side spray pot, slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 6
The extraction of extractum: it is subsequent use to get Radix Salviae Miltiorrhizae 900g, Radix Notoginseng 176g and Borneolum Syntheticum 10g; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water three times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 95% ethanol, leaves standstill 24 hours, filters, and reclaims ethanol, filtrate be concentrated under 55～60 ℃ of conditions, relative density is 1.33～1.35 thick paste 1; The Borneolum Syntheticum that will be dissolved in the adequate amount of ethanol joins in the thick paste 1, preparation cost invention Chinese medicine extract.
The preparation of master batch: the mixture of getting micropowder silica gel and Pulvis Talci weight ratio and being 1: 1 is crossed 200 mesh sieves; Wherein 50% as in the bed material input fluid bed side spray pot; Other gets PVP K30 and adds water, extract, is mixed with bonding agent and sprays into as slurry, and sift out particle diameter be 120-180 μ granule as parent nucleus, again parent nucleus is dropped in the pot; Continue the spray starch slurry; 35% micropowder silica gel and talcous fine powder of remainder is sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 200 μ-300 μ to filter out particle diameter.
The preparation of product: get the about 300g of master batch, the about 250g of microcrystalline Cellulose (200 order), the about 14g of micropowder silica gel, extractum 320g; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and it is subsequent use as slurry to mix into uniform suspension; Master batch is dropped in the fluid bed side spray pot, slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 7
The extraction of extractum: it is subsequent use to get Radix Salviae Miltiorrhizae 900g, Radix Notoginseng 176g and Borneolum Syntheticum 10g; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water three times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 95% ethanol, leaves standstill 24 hours, filters, and reclaims ethanol, filtrate be concentrated under 55 ℃ of conditions, relative density is 1.33～1.35 thick paste 1; The Borneolum Syntheticum that will be dissolved in the adequate amount of ethanol joins in the thick paste 1, preparation cost invention Chinese medicine extract.
The preparation of master batch: taking polyethylene glycol and chitosan weight ratio are that 1: 1 mixture is crossed 200 mesh sieves; Wherein 65% as in the bed material input fluid bed side spray pot; Other gets PVP K30 and adds water, extract, is mixed with bonding agent-spray into as slurry, and sift out particle diameter be 120-180 μ granule as parent nucleus, again parent nucleus is dropped in the pot; Continue the spray starch slurry; 35% the Polyethylene Glycol of remainder and the fine powder of chitosan are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 200 μ-300 μ to filter out particle diameter.
The preparation of product: get the about 700g of master batch, the about 300g of microcrystalline Cellulose (200 order), the about 20g of micropowder silica gel, extractum 650g; Microcrystalline Cellulose and micropowder silica gel are added in the extractum, and it is subsequent use as slurry to mix into uniform suspension; Master batch is dropped in the fluid bed side spray pot, slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 8:
1, the extraction of compound Salviae Miltiorrhizae extractum
Get Radix Salviae Miltiorrhizae 9kg, Radix Notoginseng 1.76kg decocte with water 3 times, decoction liquor is filtered, filtrating concentrates, and precipitate with ethanol left standstill 24 hours, filters, reclaims ethanol, and being condensed into thick paste shape to relative density is 1.33～1.35 (50～60 ℃), obtains extractum.After getting Borneolum Syntheticum and cyclodextrin or PVP enclose,, obtain compound Salviae Miltiorrhizae extractum with enclose liquid and above-mentioned extractum mix homogeneously, subsequent use.
2, the preparation of master batch
Get dextrin and starch (1: 1) mixture and cross 200 mesh sieves, wherein 65wt% drops in the fluid bed side spray pot, and other gets starch and adds water and be mixed with starch slurry (15%; G/ml) spray into as slurry, and sift out granule (particle diameter is 180～250 μ m), again parent nucleus is dropped in the pot as parent nucleus; Continue to spray and state starch slurry; Remaining 35% the dextrin and the fine powder of starch (1: 1) mixture are sprinkled in the dusting rifle simultaneously, the particle diameter of parent nucleus is grown up, it is subsequent use at the master batch of 450～600 μ m to filter out particle diameter.
3, the selection of viscosity adjustment agent
A. get above-mentioned compound Salviae Miltiorrhizae extractum, be diluted to the diluent that viscosity is 6.0～9.8MpaS with the alcoholic solution of 60% (ml/ml).
B. get 1 above-mentioned diluent, drop on the microscope slide, hang, solid cicatrix surface, liquid evaporation back does not have complete film, and viscosity is less, is prone to scrape with powdery, and it is serious to play powder.
C. the viscosity according to cicatrix among the b is little, film property is poor, intensity is little, be prone to characteristics such as powder; Select viscosity adjustment agent; Experiment shows can select HPMC: PVP-K30 (2: 5) mixture to adjust agent as viscosity, and also can select polyethylene glycol 6000 is viscosity adjustment agent.
D. selection and compound Salviae Miltiorrhizae extractum weight ratio are 7: 25 HPMC: PVP-K30 (2: 5) mixture is viscosity adjustment agent; Perhaps selection and compound Salviae Miltiorrhizae extractum weight ratio are that 18: 25 polyethylene glycol 6000 is viscosity adjustment agent, are increased to 16MPaS to material viscosity by 9.0MPaS.
4, the preparation of compound Salviae Miltiorrhizae spheroidal particle
A. get the about 450g of master batch, with compound Salviae Miltiorrhizae extractum weight ratio be 18: 25 polyethylene glycol 6000, perhaps be 7: 25 HPMC: PVP-K30 (2: 5) mixture, 450g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum with compound Salviae Miltiorrhizae extractum weight ratio;
B. use dehydrated alcohol with a kind of solution that is formulated as concentration as 15wt% in the above-mentioned viscosity adjustment agent, add in the compound Salviae Miltiorrhizae extractum, after the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 19wt%, as slurry;
C. master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle; Temperature of charge is controlled at 37～45 ℃; Again transparent coating material water is made into the coating solution of 7.5% (g/ml), coating solution is sprayed into coating, process spheroidal particle according to the amount of theory weightening finish 3wt%; Its bulk density is 0.76g/ml, and dissolve scattered time limit is 25 seconds.
With No. 2 capsules of the spheroidal particle fill that obtains among the step c, the 250mg/ grain is processed capsule.
Embodiment 9
1, the extraction of extractum: Radix Salviae Miltiorrhizae 30kg, Radix Notoginseng 5kg and Borneolum Syntheticum 0.3kg are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 5 times, collecting decoction filters, filtrating concentrates, and adds 5 times of amount 80% ethanol, leaves standstill 12 hours, filters, and reclaims ethanol, filtrate be concentrated under 30 ℃ of conditions, relative density is 1.05～1.45 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
2, the preparation of master batch: get xylitol and carboxymethyl starch sodium (1: 1) mixture and cross 200 mesh sieves; Wherein 60wt% drops in the fluid bed side spray pot, and other gets 10wt% xylitol and carboxymethyl starch sodium (1: 1) mixture and extract extractum of the present invention (after amounting to dry weight, accounting for the 15wt% of master batch weight) and adds water and be mixed with slurry and spray into; And sift out granule (particle diameter is 180～250 μ m) as parent nucleus; Again parent nucleus is dropped in the pot, continue to spray and state slurry, in the dusting rifle, the xylitol of remaining 30wt% and the fine powder of carboxymethyl starch sodium (1: 1) mixture are sprinkled into simultaneously; The particle diameter of parent nucleus is grown up, and the master batch that filters out particle diameter and be 280～450 μ m is subsequent use.
3, the preparation of product: get the about 450g of master batch; 350g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum, with compound Salviae Miltiorrhizae extractum weight ratio be 18: 25 polyethylene glycol 6000, use dehydrated alcohol that above-mentioned viscosity adjustment agent polyethylene glycol 6000 is formulated as the solution of concentration as 15wt%; Add in the compound Salviae Miltiorrhizae extractum; After the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 19wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 10
1, the extraction of extractum: Radix Salviae Miltiorrhizae 180kg, Radix Notoginseng 40kg and Borneolum Syntheticum 2.5kg are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 3 times, collecting decoction filters, filtrating concentrates, and adds 3 times of amount 96% ethanol, leaves standstill 36 hours, filters, and reclaims ethanol, filtrate be concentrated under 80 ℃ of conditions, relative density is 1.05～1.45 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
2, the preparation of master batch: get lactose and hydroxypropyl starch (1: 1) mixture and cross 200 mesh sieves; Wherein 60wt% drops in the fluid bed side spray pot, and other gets 10wt% lactose and hydroxypropyl starch (1: 1) mixture and extract extractum of the present invention (after amounting to dry weight, accounting for the 15wt% of master batch weight) and adds water and be mixed with slurry and spray into; And sift out granule (particle diameter is 180～250 μ m) as parent nucleus; Again parent nucleus is dropped in the pot, continue to spray and state slurry, in the dusting rifle, the lactose of remaining 30wt% and the fine powder of hydroxypropyl starch (1: 1) mixture are sprinkled into simultaneously; The particle diameter of parent nucleus is grown up, and the master batch that filters out particle diameter and be 180～250 μ m is subsequent use.
3, the preparation of product: get the about 850g of master batch, 1000g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum, with compound Salviae Miltiorrhizae extractum weight ratio be 7: 25 HPMC and PVP-K30 mixture, wherein HPMC: the PVP-K30 weight ratio is 2: 5; Use dehydrated alcohol that above-mentioned viscosity adjustment agent HPMC is formulated as the solution of concentration as 15wt% with the PVP-K30 mixture, in the adding compound Salviae Miltiorrhizae extractum, after the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 20wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 11
1, the extraction of extractum: Radix Salviae Miltiorrhizae 115kg, Radix Notoginseng 20kg and Borneolum Syntheticum 1.2kg are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 2 times, collecting decoction filters, filtrating concentrates, and adds 3 times of amount 97% ethanol, leaves standstill 30 hours, filters, and reclaims ethanol, filtrate be concentrated under 75 ℃ of conditions, relative density is 1.20～1.40 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
2, the preparation of master batch: get dextrin and mannitol (3: 1) mixture and cross 200 mesh sieves; Wherein 64wt% drops in the fluid bed side spray pot, and other gets 16wt% dextrin and mannitol mixture and extract extractum of the present invention (after amounting to dry weight, accounting for the 10wt% of master batch weight) and adds water and be mixed with slurry and spray into; And sift out granule (particle diameter is 180～250 μ m) as parent nucleus; Again parent nucleus is dropped in the pot, continue to spray and state slurry, in the dusting rifle, the dextrin of remaining 20wt% and the fine powder of mannitol mixture are sprinkled into simultaneously; The particle diameter of parent nucleus is grown up, and the master batch that filters out particle diameter and be 450～600 μ m is subsequent use.
3, the preparation of product: get the about 500g of master batch, 550g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum, with compound Salviae Miltiorrhizae extractum weight ratio be 7: 25 HPMC and PVP-K30 mixture, wherein HPMC: the PVP-K30 weight ratio is 2: 5; Use dehydrated alcohol that above-mentioned viscosity adjustment agent HPMC is formulated as the solution of concentration as 15wt% with the PVP-K30 mixture, in the adding compound Salviae Miltiorrhizae extractum, after the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 20wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Embodiment 12
1, the extraction of extractum: Radix Salviae Miltiorrhizae 75kg, Radix Notoginseng 14kg and Borneolum Syntheticum 0.8kg are subsequent use; Radix Salviae Miltiorrhizae, Radix Notoginseng decocte with water 4 times, collecting decoction filters, filtrating concentrates, and adds 2 times of amount 90% ethanol, leaves standstill 18 hours, filters, and reclaims ethanol, filtrate be concentrated under 50 ℃ of conditions, relative density is 1.20～1.40 thick paste 1; Finely divided ice tablet of Borneolum Syntheticum that perhaps is dissolved in the adequate amount of ethanol joined in the thick paste 1 preparation cost invention Chinese medicine extract.
2, the preparation of master batch: get dextrin and mannitol (2: 1) mixture and cross 200 mesh sieves; Wherein 65wt% drops in the fluid bed side spray pot, and other gets 25wt% dextrin and mannitol mixture and extract extractum of the present invention (after amounting to dry weight, accounting for the 10wt% of master batch weight) and adds water and be mixed with slurry and spray into; And sift out granule (particle diameter is 180～250 μ m) as parent nucleus; Again parent nucleus is dropped in the pot, continue to spray and state slurry, in the dusting rifle, the dextrin of remaining 10wt% and the fine powder of mannitol mixture are sprinkled into simultaneously; The particle diameter of parent nucleus is grown up, and the master batch that filters out particle diameter and be 450～600 μ m is subsequent use.
3, the preparation of product: get the about 450g of master batch; 850g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum, with compound Salviae Miltiorrhizae extractum weight ratio be 18: 25 polyethylene glycol 6000, use dehydrated alcohol that above-mentioned viscosity adjustment agent polyethylene glycol 6000 is formulated as the solution of concentration as 15wt%; Add in the compound Salviae Miltiorrhizae extractum; After the mixing, adding 60% (ml/ml) ethanol, to transfer to solids content be 19wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
Claims (6)
1. method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract is characterized in that step is following:
(1) preparation of extract is obtained by following materials of weight proportions as follows: 1 part of 90 parts of Radix Salviae Miltiorrhizaes, 17.6 parts of Radix Notoginseng and Borneolum Syntheticum; Get Radix Salviae Miltiorrhizae, the Radix Notoginseng decocte with water 3 times of said ratio, decoction liquor is filtered, filtrating concentrates, and precipitate with ethanol left standstill 24 hours, filters, reclaims ethanol, and relative density is 1.33～1.35 when being condensed into thick paste shape to 50～60 ℃, obtains extractum; After getting Borneolum Syntheticum and cyclodextrin or PVP enclose,, obtain compound Salviae Miltiorrhizae extractum with enclose liquid and above-mentioned extractum mix homogeneously, subsequent use;
(2) preparation of master batch: the mixture of getting dextrin and starch weight ratio and being 1: 1 is crossed 200 mesh sieves, and wherein 60-65wt% drops in the fluid bed side spray pot as bed material; 10-15wt% dextrin and starch mixture, amount to the extract extractum of the present invention that accounts for the 15wt% of master batch weight after the dry weight; Add water and be mixed with slurry and spray into, and sift out particle diameter be 180～250 μ m granules as parent nucleus, again parent nucleus is dropped in the pot; Continue to spray and state slurry; In the dusting rifle, the dextrin of surplus and the fine powder of starch mixture are sprinkled into simultaneously, the particle diameter of parent nucleus is grown up, the master batch that filters out particle diameter and be 450～600 μ m is subsequent use;
(3) preparation of product: get the about 450g of master batch; 100～1000g compound Salviae Miltiorrhizae extractum and Borneolum Syntheticum; With compound Salviae Miltiorrhizae extractum weight ratio be 18: 25 polyethylene glycol 6000; Perhaps be 7: 25 HPMC and PVP-K30 mixture, wherein HPMC with compound Salviae Miltiorrhizae extractum weight ratio: the PVP-K30 weight ratio is 2: 5; Use dehydrated alcohol with a kind of solution that is formulated as concentration as 15wt% in above-mentioned viscosity adjustment agent polyethylene glycol 6000 or HPMC and the PVP-K30 mixture, in the adding compound Salviae Miltiorrhizae extractum, after the mixing, adding 60% ethanol, to transfer to solids content be 19wt%, as slurry; Master batch is dropped in the fluid bed side spray pot, above-mentioned slurry is slowly sprayed into, constantly be dried to slurry simultaneously and all spray into and process spheroidal particle.
2. the method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract according to claim 1, the temperature of charge of the spheroidal particle that it is characterized in that said method is obtained is controlled at 37～45 ℃; Transparent coating material water is made into 7.5% coating solution again, according to the amount of theory weightening finish 3wt% coating solution is sprayed into coating, process spheroidal particle, its bulk density is 0.76g/ml, and dissolve scattered time limit is 25 seconds.
3. the method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract according to claim 1; It is characterized in that prepared granule comprises master batch and is positioned at the shell on the master batch; Profile is spherical or type sphere; Bulk density is 0.6～1.3g/m, and dissolve scattered time limit is 0.4～5 minute, and active constituents of medicine is included among master batch and/or the shell.
4. the method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract according to claim 1 is characterized in that its particle diameter of prepared granule is 700～1500 μ m.
5. the method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract according to claim 1 is characterized in that prepared granule also contains coating, and the weight of coating materials accounts for 2～5wt% of granule gross weight.
6. like each said method for preparing that contains the Chinese medicinal granule of Radix Salviae Miltiorrhizae extract of claim 1-5, it is characterized in that the 250mg/ grain is processed 10000 of capsules with No. 2 capsules of spheroidal particle fill of said method acquisition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101503224A CN101439087B (en) | 2007-11-22 | 2007-11-22 | Chinese medicine granule containing salvia root extract and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101503224A CN101439087B (en) | 2007-11-22 | 2007-11-22 | Chinese medicine granule containing salvia root extract and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101439087A CN101439087A (en) | 2009-05-27 |
| CN101439087B true CN101439087B (en) | 2012-03-28 |
Family
ID=40723785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101503224A Active CN101439087B (en) | 2007-11-22 | 2007-11-22 | Chinese medicine granule containing salvia root extract and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101439087B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102028742B (en) * | 2009-09-29 | 2013-09-04 | 天津天士力现代中药资源有限公司 | Drug for treating coronary heart disease and extraction method thereof |
| CN104224726B (en) * | 2013-06-17 | 2018-04-03 | 天士力医药集团股份有限公司 | A kind of preparation method of traditional Chinese medicine pellet |
-
2007
- 2007-11-22 CN CN2007101503224A patent/CN101439087B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101439087A (en) | 2009-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101472565B (en) | Preparation method of granular formulation | |
| CN101439135B (en) | Chinese medicine granule containing extract of grassleaved sweetflag rhizome and preparation method thereof | |
| CN101439076B (en) | Preparation method of chinese medicine granule containing dalbergia heartwood oil | |
| CN101439057B (en) | Chinese medicine granule containing gingko extract and preparation method thereof | |
| CN101439067B (en) | Chinese medicine granular containing ginseng extract and preparation method thereof | |
| CN101439087B (en) | Chinese medicine granule containing salvia root extract and preparation method thereof | |
| CN101439062B (en) | Chinese medicine granule containing andrographolide and preparation method thereof | |
| CN101439065B (en) | Chinese medicine granular containing notoginseng extract and preparation method thereof | |
| CN101439063B (en) | Chinese medicine granular formulation containing Chinese angelica extract and preparation method thereof | |
| CN101439084B (en) | Chinese medicine granule containing agastache extract and preparation method thereof | |
| CN101439041B (en) | Chinese medicine granule containing breviscapine and preparation method thereof | |
| CN101439107B (en) | Chinese medicine granule containing haw thorn extract and preparation method thereof | |
| CN101439066B (en) | Chinese medicine granular containing notoginseng extract and preparation method thereof | |
| CN101439068B (en) | Chinese medicine granule containing silymarin and preparation method thereof | |
| CN101439086B (en) | Chinese medicine granule containing total phenolic acids in salvia root and preparation method thereof | |
| CN101439082B (en) | Chinese medicine granule containing sophora root extract and preparation method thereof | |
| CN101439085B (en) | Chinese medicine granule containing agastache extract and preparation method thereof | |
| CN101439126B (en) | Chinese medicine granule containing Huangyangning and preparation method thereof | |
| CN101439105B (en) | Chinese medicine granule containing spina date seed extract and preparation method thereof | |
| CN101439078B (en) | Chinese medicine granule containing astragalus extract and preparation method thereof | |
| CN101439079B (en) | Preparation method of Chinese medicine granule containing total saponins in astragalus | |
| CN101439058B (en) | Compound Chinese medicine gingko granule and preparation method thereof | |
| CN101439099B (en) | Chinese medicine granule containing red paeonia extract and preparation method thereof | |
| CN101439122B (en) | Chinese medicine granule containing prepared rehmannia root extract and preparation method thereof | |
| CN101439143B (en) | Chinese medicine granules containing Anemarrhena asphodefoides extract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tasly Pharmaceutical Group Co., Ltd. |